Bifunctional peptide hybrids targeting the matrix of mitochondria
Authors:
- 1 December 2018
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 291, 147-156
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Targeting mitochondria for cancer therapyNature Reviews Drug Discovery, 2010
- Insertion of a Lysosomal Enzyme Cleavage Site into the Sequence of a Radiolabeled Neuropeptide Influences Cell Trafficking In Vitro and In VivoCancer Biotherapy and Radiopharmaceuticals, 2010
- Outer Mitochondrial Membrane Localization of Apoptosis-Inducing Factor: Mechanistic Implications for ReleaseASN Neuro, 2009
- Fusion of a Short HA2-Derived Peptide Sequence to Cell-Penetrating Peptides Improves Cytosolic Uptake, but Enhances Cytotoxic ActivityPharmaceuticals, 2009
- Nanoparticles in cellular drug deliveryBioorganic & Medicinal Chemistry, 2009
- Mitochondrial dysfunction and oxidative stress in neurodegenerative diseasesNature, 2006
- Cell-permeable, mitochondrial-targeted, peptide antioxidantsThe AAPS Journal, 2006
- A Mitochondrial Paradigm of Metabolic and Degenerative Diseases, Aging, and Cancer: A Dawn for Evolutionary MedicineAnnual Review of Genetics, 2005
- Apoptosis Induction by Caspase-8 Is Amplified through the Mitochondrial Release of Cytochrome cJournal of Biological Chemistry, 1998
- 2D NMR and structural model for a mitochondrial signal peptide bound to a micelleBiochemistry, 1990